Post-earnings recap
Reported
Tue, Mar 7, 2017
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
50%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Axsome Therapeutics reported a loss of $0.38 per share, but no revenue figures were provided. The stock reacted negatively, dropping 9.18%, indicating investor concern over the lack of financial performance details and future guidance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.38 | N/A | — |
| Revenue | — | N/A | — |
No transcript is on record, and the analysis is based on numerical results only.